AnalystsLisa WalterLisa Walter's Stock Forecasts
AnalystsLisa Walter
Sectors:
Industries:
Analyst Ranking
Bottom 22%
#4128 out of 5231 analysts
Average Return
-1.47%
Win Rate
43%6 out of 14
Risk vs Reward
Poor
Good
Lisa Walter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
United Therapeutics CorpUTHR | +35.99% | $432.66 | $588.36 | 2025-09-25 - 2026-03-30 | Buy |
Eyepoint IncEYPT | +34.51% | $8.81 | $11.85 | 2025-06-16 - 2026-03-30 | Buy |
United Therapeutics CorpUTHR | +29.73% | $453.53 | $588.36 | 2025-10-29 - 2026-03-30 | Buy |
United Therapeutics CorpUTHR | +16.83% | $503.60 | $588.36 | 2026-02-25 - 2026-03-30 | Buy |
Viridian Therapeutics IncVRDN | +12.10% | $16.53 | $18.53 | 2025-08-06 - 2026-03-30 | Buy |
Lisa Walter Analyst Color
Get additional color on Lisa Walter's coverage of popular stocks
Lisa Walter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
4d Molecular Therapeutics IncFDMT | 3 | Buy | $35.00 | +308.40% | Maintains | 12 days ago |
Rhythm Pharmaceuticals IncRYTM | 2 | Buy | $130.00 | +68.28% | Maintains | 14 days ago |
Viridian Therapeutics IncVRDN | 3 | Buy | $42.00 | +126.66% | Maintains | a month ago |
United Therapeutics CorpUTHR | 3 | Buy | $643.00 | +9.29% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $21.00 | +22.88% | Maintains | a month ago |
Meiragtx Holdings PLCMGTX | 1 | Buy | $16.00 | +97.78% | Maintains | 5 months ago |
Eyepoint IncEYPT | 2 | Buy | $39.00 | +229.11% | Maintains | 5 months ago |
Adverum Biotechnologies IncADVM | 1 | Hold | $4.00 | -8.26% | Maintains | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.